FullWell Launches First-of-Its-Kind Study to Answer a Longstanding Folate Question and Advance the Future of Women's Health Research
Landmark IRB-approved study will compare methylfolate and folic acid head-to-head while tracking both biological markers and real-world reproductive outcomes BOSTON, Sept. 15, 2026 /PRNewswire/ -- FullWell, the reproductive wellness brand known for its evidence-based formulas founded by...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.